{
    "comments": "Dulaglutide is a GLP-1 mimetic. This treatment has the benefit of being long-acting, with <i>in vivo</i> studies showing peptide immunoreactivity is detactable &gt;6 days following administration <Reference id=25170/>. Therefore dulaglutide requires administration only once a week <Reference id=44295/>.",
    "bioactivityComments": "",
    "clinicalUse": "Dulaglutide is approved to improve blood sugar levels adults with type 2 diabetes, in conjunction with diet and excercise.",
    "mechanismOfAction": "This synthetic peptide mimics the action of GLP-1 at the <a href=\"ObjectDisplayForward?objectId=249\">GLP-1 receptor</a>.",
    "absorptionAndDistribution": "",
    "metabolism": "",
    "elimination": "",
    "populationPharmacokinetics": "",
    "organFunctionImpairment": "",
    "immuno": "",
    "gtmp": ""
}